Enhance quality and value in cancer care and get rewards when you treat patients using therapies associated with better clinical outcomes. Cancer Therapy Pathways are detailed, evidence-based regimens selected through rigorous evaluation for specific cancer types and stages.
To participate, review the following eligibility and reward information. Then, simply start a new prior authorization request and select the appropriate regimen. You can track your participation in the Optum dashboard.
You can participate if:
You can earn rewards for using UnitedHealthcare Cancer Therapy Pathways if:
You may receive (subject to all applicable program requirements, terms and conditions) a $1,000 cash payment for each pathway regimen selected when:
Regimens are based on a comprehensive literature review of all National Comprehensive Cancer Network (NCCN) recommended regimens.
Selection of a regimen is based on efficacy, safety/toxicity and drug cost. (Drug cost is reviewed only when efficacy and safety between regimens are comparable). We also consider UnitedHealthcare data for the duration of therapy, hospitalization rates and total cost of care.
The UnitedHealthcare Oncology Advisory Committee and disease-specific expert consultants review evaluate each pathway. Members of this committee are selected for their clinical expertise to help ensure diverse perspectives. This includes practicing medical oncologists from academic medical centers and community oncology practices who are not employed by UnitedHealthcare.
Information on this page is current as of August 2021.